CTOs on the Move

Biorasi

www.biorasi.com

 
Biorasi is an award-winning full service, global Clinical Research Optimized (CRO). From project design to execution success, optimization is engrained in ProAct+. An integrated platform of high performance systems, tools, and processes. By developing and implementing groundbreaking methods of optimizing clinical research, we contribute to enhancement of health and well-being for people around the world.    Powered by ProAct+, Biorasi`s full service project teams have developed numerous drugs, biologics and devices that received FDA and multi-venue approvals. Biorasi is headquartered in Miami, FL and has regional operations around the world.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.biorasi.com
  • One Turnberry Place 19495 Biscayne Blvd. Suite #900
    Miami, FL USA 33180
  • Phone: 786.388.0700
  • Fax: 786.388.6044

Executives

Name Title Contact Details
Melissa Bomben
Chief Operating Officer Profile

Jobs

Chief Marketing Officer

Biorasi Aventura, FL
The Role
Reporting directly to the Chairman and CEO, the Chief Marketing Officer will be a member of the company`s executive team. S/he will be responsible for growing bookings and backlog. The Marketing Development infrastructure will report directly to you and you will work closely interfacing with Divisional Operations ...

Similar Companies

Prescription Corporation of America

Prescription Corporation of America is a Denville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PGM Plastics

PGM Plastics Inc. is a Fitchburg, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Eloxx Pharmaceuticals

Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates that are designed to treat rare and ultra-rare premature stop codon diseases. Premature stop codons are point mutations that disrupt protein synthesis from messenger RNA. As a consequence, patients with premature stop codon diseases have reduced or eliminated protein production from the mutation bearing allele accounting for some of the most severe phenotypes in these genetic diseases. These premature stop codons have been identified in over 1,800 rare and ultra-rare diseases. Read-through therapeutic development is focused on extending mRNA half-life and increasing protein synthesis by enabling the cytoplasmic ribosome to read through premature stop codons to produce full-length proteins. Eloxx`s lead product candidate, ELX-02, is a small molecule drug candidate designed to restore production of full-length functional proteins. ELX-02 is in the early stages of clinical development focusing on cystic fibrosis and cystinosis. ELX-02 is an investigational drug that has not been approved by any global regulatory body. Eloxx is headquartered in Waltham, MA, with R&D operations in Rehovot, Israel.

Alliance Health Networks

Alliance Health Networks is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PCA Pharmacy

PCA Pharmacy is a Louisville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.